J-Pharma Co.,Ltd. 520AShort Interest
Estimated short interest in J-Pharma Co.,Ltd. (520A) is 0.73% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd.
Estimated short interest
0.73%
±0.00%
Estimated position (shares)
133,000
As of 2026-11-18
Holders (0.5% or more)
1 firms
51 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2026-09-02 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 0.47%) |
| Reporting institutions | 3 firms (51 reports) |
| Peak estimated short interest | 3.05% (2026-10-06, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- Nomura International plc
- Morgan Stanley MUFG Securities Co., Ltd.
0.73%
Estimated short interest, 2026-11-18
Barclays Capital Securities Ltd0.73%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-04 | Barclays Capital Securities Ltd | Position 133,000 shares | Ratio 0.73% | ▲0.11% | Holding |
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 85,300 shares | Ratio 0.47% | ▼0.08% | Below 0.5% |
| 2026-10-26 | Nomura International plc | Position 78,800 shares | Ratio 0.43% | ▼0.15% | Below 0.5% |
Disclosure History 51 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 85,300 shares | Ratio 0.47% | ▼0.08% | Below 0.5% |
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 99,500 shares | Ratio 0.55% | ▲0.07% | — |
| 2026-11-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 88,500 shares | Ratio 0.48% | ▼0.09% | Below 0.5% |
| 2026-11-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 103,400 shares | Ratio 0.57% | ▼0.10% | — |
| 2026-11-04 | Barclays Capital Securities Ltd | Position 133,000 shares | Ratio 0.73% | ▲0.11% | — |
| 2026-11-02 | Morgan Stanley MUFG Securities Co., Ltd. | Position 122,200 shares | Ratio 0.67% | ▲0.09% | — |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 112,600 shares | Ratio 0.62% | ▲0.06% | — |
| 2026-10-28 | Barclays Capital Securities Ltd | Position 102,600 shares | Ratio 0.56% | ▼0.06% | — |
| 2026-10-27 | Barclays Capital Securities Ltd | Position 112,000 shares | Ratio 0.62% | ▼0.15% | — |
| 2026-10-26 | Nomura International plc | Position 78,800 shares | Ratio 0.43% | ▼0.15% | Below 0.5% |
| 2026-10-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 105,300 shares | Ratio 0.58% | ▼0.29% | — |
| 2026-10-22 | Morgan Stanley MUFG Securities Co., Ltd. | Position 157,400 shares | Ratio 0.87% | ▼0.09% | — |
| 2026-10-21 | Barclays Capital Securities Ltd | Position 139,900 shares | Ratio 0.77% | ▼0.11% | — |
| 2026-10-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 173,500 shares | Ratio 0.96% | ▼0.13% | — |
| 2026-10-20 | Nomura International plc | Position 106,300 shares | Ratio 0.58% | ▼0.11% | — |
| 2026-10-19 | Morgan Stanley MUFG Securities Co., Ltd. | Position 197,100 shares | Ratio 1.09% | ▼0.05% | — |
| 2026-10-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 206,500 shares | Ratio 1.14% | ▼0.15% | — |
| 2026-10-15 | Nomura International plc | Position 125,200 shares | Ratio 0.69% | ▼0.06% | — |
| 2026-10-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 233,500 shares | Ratio 1.29% | ▼0.03% | — |
| 2026-10-09 | Barclays Capital Securities Ltd | Position 160,700 shares | Ratio 0.88% | ▼0.15% | — |
| 2026-10-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 239,600 shares | Ratio 1.32% | ▲0.19% | — |
| 2026-10-09 | Nomura International plc | Position 135,700 shares | Ratio 0.75% | ▼0.07% | — |
| 2026-10-08 | Nomura International plc | Position 148,700 shares | Ratio 0.82% | ▼0.14% | — |
| 2026-10-08 | Barclays Capital Securities Ltd | Position 187,600 shares | Ratio 1.03% | ▲0.09% | — |
| 2026-10-07 | Nomura International plc | Position 175,000 shares | Ratio 0.96% | ▼0.08% | — |
| 2026-10-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 204,100 shares | Ratio 1.13% | ▲0.06% | — |
| 2026-10-06 | Nomura International plc | Position 189,100 shares | Ratio 1.04% | ▼0.10% | — |
| 2026-10-06 | Barclays Capital Securities Ltd | Position 170,000 shares | Ratio 0.94% | ▼0.06% | — |
| 2026-10-06 | Morgan Stanley MUFG Securities Co., Ltd. | Position 194,800 shares | Ratio 1.07% | ▲0.52% | — |
| 2026-10-05 | Nomura International plc | Position 206,300 shares | Ratio 1.14% | ▲0.35% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chordia Therapeutics Inc.190A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAUNS Laboratories,Inc.197A | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PRISM BioLab Co.,LTD206A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cyfuse Biomedical K.K.4892 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Noile-Immune Biotech Inc.4893 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cuorips Inc.4894 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| K Pharma,Inc.4896 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |